Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, pharmacokinetics, and preliminary effectiveness of AGS-16C3F as monotherapy in renal cell carcinoma with clear cell or papillary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Papillary Renal Cell Carcinoma
• Renal Cell Carcinoma
• Renal Cell Carcinoma Non-clear Cell

Drugs mentioned

• AGS-16C3F

Snippet

Sponsor: Agensys, Inc. | Conditions: Carcinoma, Renal Cell, Renal Cell Carcinoma of Papillary Histology | Phase 1 | Status: COMPLETED